BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16563104)

  • 1. Current concepts in the management of heart failure.
    Young R; Worthley LI
    Crit Care Resusc; 2004 Mar; 6(1):31-53. PubMed ID: 16563104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dyspnea and normal systolic function].
    Hasenfuss G; Hermann HP; Pieske B
    Herz; 2004 Sep; 29(6):602-8. PubMed ID: 15912435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives for AT(1)-receptor blockers in the management of heart failure.
    Swedberg K
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S47-51. PubMed ID: 12140728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure with normal left ventricular ejection fraction: what is the evidence?
    Kindermann M; Reil JC; Pieske B; van Veldhuisen DJ; Böhm M
    Trends Cardiovasc Med; 2008 Nov; 18(8):280-92. PubMed ID: 19345315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic heart failure: challenges of diagnosis and treatment.
    Gutierrez C; Blanchard DG
    Am Fam Physician; 2004 Jun; 69(11):2609-16. PubMed ID: 15202695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics, treatment and short-term morbidity and mortality of patients with heart failure followed in heart failure clinics. Results of the BADAPIC Registry].
    Anguita Sánchez M;
    Rev Esp Cardiol; 2004 Dec; 57(12):1159-69. PubMed ID: 15617639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic heart failure: current evidence, challenges to therapy, and future directions.
    Morrissey RP; Czer L; Shah PK
    Am J Cardiovasc Drugs; 2011 Jun; 11(3):153-71. PubMed ID: 21619379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High output heart failure.
    Mehta PA; Dubrey SW
    QJM; 2009 Apr; 102(4):235-41. PubMed ID: 18990720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts in the use of digitalis.
    Antman EM; Smith TW
    Adv Intern Med; 1989; 34():425-54. PubMed ID: 2644767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure.
    Chinnaiyan KM; Alexander D; Maddens M; McCullough PA
    Am Heart J; 2007 Feb; 153(2):189-200. PubMed ID: 17239676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of therapy for advanced heart failure.
    Stevenson LW
    Eur J Heart Fail; 2005 Mar; 7(3):323-31. PubMed ID: 15718172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.